Israeli researchers find ‘potential hope’ for some pancreatic cancer patients

(THIS ARTICLE IS COURTESY OF THE TIMES OF ISRAEL)

 

Israeli researchers find ‘potential hope’ for some pancreatic cancer patients

New drug stalls progression of disease for patients who have the BRCA genetic mutations, study by Sheba Medical Center with AstraZeneca and Merck shows

An illustrative image of a cancer patient and perfusion drip. (CIPhotos, iStock by Getty Images)

An illustrative image of a cancer patient and perfusion drip. (CIPhotos, iStock by Getty Images)

Researchers at Israel’s Sheba Medical Center at Tel Hashomer said Sunday that a targeted cancer therapy drug they developed together with pharma giants AstraZeneca and Merck & Co. Inc. offers “potential hope” for patients with a specific kind of pancreatic cancer, as it delays the progression of the disease.

Dr. Talia Golan, the head of the Sheba Medical Center Pancreatic Cancer Center, has been conducting research and clinical trials with AstraZeneca and MSD, as Merck is called outside the US, to evaluate the safety and test the efficacy of a new drug treatment regimen based on Lynparza, or olaprib, tablets.

The tablets are a pharmacological inhibitor of the enzyme poly (ADP-ribose) polymerase, or PARP. PARP inhibitors are a group of drugs that inhibit the enzyme. They were developed for a number of indications, but most importantly for the treatment of cancer, as several forms of cancer are more dependent for their development on the enzyme than regular cells are. This makes PARP an attractive target for cancer therapy.

Those who received the medication in the study on average went 7.4 months before their disease began to worsen, known as “progression free survival” rates, compared to 3.8 months in the group that took the placebo, the researchers said.

The study, called POLO, was held with 154 patients with metastatic pancreatic cancer who carried the BRC -1 and BRCA-2 genetic mutations. Patients with these mutations “make up a small subgroup of those with metastatic pancreatic cancer,” the researchers said in their study. Golan said in an interview that this subgroup accounts for six to seven percent of the metastatic pancreatic cancer patients.

The results of the Phase III randomized, double-blind study with a placebo control group will be published in July in the New England Journal of Medicine, the partners said.

“The POLO trial using the medicine Lynparza offers potential hope for those who suffer from metastatic pancreatic cancer and have a BRCA mutation,” Golan said in the statement. “This treatment also exemplifies the advent of ‘precision medicine’ based on a specific genetic biomarker, BRCA 1 & 2.”

In the study, patients were randomly assigned to get the tablets, at a dose of 300 milligram twice daily, or a placebo.

However, though the drug was seen to slow the disease’s progression, an interim analysis showed “no difference” in overall survival between those who took the drug and the placebo group — a median of 18.9 months versus 18.1 months, the study said.

Pancreatic cancer is the 12th most common cancer worldwide, with 458,918 new cases in 2018 alone. It is the fourth leading cause of cancer death, and accounts for 7% of all cancer deaths, according to Cancer.Net. The five-year survival rate for people with pancreatic cancer is 9%. The cancer is often difficult to diagnose, as there are no specific cost-effective ways to screen for the illness, meaning that it is often found at later stages, when it has spread. For the 52% of people who are diagnosed after the cancer has spread, the 5-year survival rate is 3%, Cancer.Net says.

“When we saw the results were positive it was an exceptional, phenomenal moment,” said Golan in an interview. “For the field it is a huge thing.”

She added that this is the first Phase 3 biomarker study that is positive in pancreatic cancer and the drug “provides tremendous hope for patients” with the advanced stage of the cancer.  “This drug has shown efficacy and a tremendous really phenomenal response in this patient population,” she said.

BRCA1 and BRCA2 are human genes that produce proteins responsible for repairing damaged DNA and play an important role in maintaining the genetic stability of cells. When either of these genes is mutated, or altered, such that its protein product either is not made or does not function correctly, DNA damage may not be repaired properly, and cells become unstable. As a result, cells are more likely to develop additional genetic alterations that can lead to cancer. A significant number of Ashkenazi Jews (those of European origin) around the world are carriers of the BRCA 1 & 2 genes.

READ MORE:
COMMENTS

JUNE 4, 2019
CURRENT TOP STORIES

Mother of Nechama Rivlin’s lung donor: ‘Another part of you has gone’

Sari Halabli, mother of 19-year-old Yair who died in March drowning accident, eulogizes president‘s ‘modest’ wife, says she will ‘rest in peace, together with my enchanting son’

Nechama Rivlin (R), wife of President Reuven Rivlin, on June 16, 2016. (Moshe Shai/FLASH90)
Yair Yehezkel Halabli (L), who donated his lung to Rivlin. (Twitter)

Nechama Rivlin (R), wife of President Reuven Rivlin, on June 16, 2016. (Moshe Shai/FLASH90) Yair Yehezkel Halabli (L), who donated his lung to Rivlin. (Twitter)

The mother of the young man whose lung was transplanted into Nechama Rivlin said Tuesday she grieves the passing of President Reuven Rivlin’s wife.

Sari Halabli, the mother of 19-year-old Yair Halabli, who died in March after drowning in a diving accident in Eilat, said Rivlin’s death at the age of 73 meant another part of her son had died.

Rivlin was “a modest woman, just like Yair,” Halabli told the Ynet news site.

“Rest in peace, together with my enchanting son,” she said in a message to Rivlin, before addressing her late son: “Another part of you has gone, and of my heart.”

Memorial candles are lit next to a picture of Nechama Rivlin, the late wife of President Reuven Rivlin, outside the President’s Residence in Jerusalem on June 4, 2019. (Yonatan Sindel/Flash90)

Halabli’s family donated several of his organs after his death. Rivlin received his lung on March 11 after a long time on a waiting list as she suffered from pulmonary fibrosis, a condition in which scar tissue accumulates in the lungs and makes it difficult to breathe. She died earlier Tuesday from complications linked to the transplant.

Her funeral will be held Wednesday at 6 p.m. at the Mount Herzl national cemetery in Jerusalem. Prior to the ceremony, her coffin will be placed at the Jerusalem Theater, where the public can go to pay its respects.

On Thursday and Friday, the president and his family will receive condolence visits at his official residence in Jerusalem as part of the traditional Shiva mourning period.

“I’m happy Nechama is no longer suffering. She really deserves the love she is getting now and the recognition of her service and work,” Channel 12 news quoted Rivlin telling friends following his wife’s death.

Rivlin died on the eve of her 74th birthday at Beilinson Hospital in Petah Tikva, where she was being treated after relapsing following the lung transplant.

President Reuven Rivlin and his wife, Nechama Rivlin. (GPO)

Soft-spoken and mild-mannered, Rivlin was eulogized by Israeli politiciansfrom across the political spectrum. She was also mourned by foreign diplomats stationed in Israel, as well as US President Donald Trump’s envoy for Middle East peace.

Trump, French President Emmanuel Macron and German President Frank Walter Steinmeier all called Rivlin’s office to express their condolences, according to Channel 12, which reported the president only spoke by phone with a few close friends of his and his late wife’s.

Nechama Rivlin was born in 1945 in Moshav Herut in the Sharon region. She married Reuven Rivlin in 1971, and worked for many years at the Hebrew University of Jerusalem, until her retirement in 2007, at which point her lung condition was discovered.

READ MORE:
COMMENTS
MORE

 

 

How the humble cabbage can stop cancers

(THIS ARTICLE IS COURTESY OF THE BBC)

 

How the humble cabbage can stop cancers

CabbageImage copyright GETTY IMAGES

Scientists say they have discovered why some vegetables – including cabbage, broccoli and kale – can reduce the risk of bowel cancers.

That cruciferous veg is good for the gut has never been in doubt but a detailed explanation has been elusive.

The team at the Francis Crick Institute found anti-cancer chemicals were produced as the vegetables were digested.

Cancer Research UK said there were plenty of reasons to eat more veg.

The work focused on how vegetables alter the lining of the intestines, by studying mice and miniature bowels growing in the lab.

Like the skin, the surface of the bowels is constantly being regenerated in a process that takes four to five days.

But this constant renewal needs to be tightly controlled, otherwise it could lead to cancer or gut inflammation.

And the work, published in the journal Immunity, showed chemicals in cruciferous vegetables were vital.

From kitchen to cancer prevention?

The researchers investigated a chemical called indole-3-carbinol, which is produced by chewing such vegetables.

“Make sure they’re not overcooked, no soggy broccoli,” said researcher Dr Gitta Stockinger.

The chemical is modified by stomach acid as it continues its journey through the digestive system.

In the lower bowel, it can change the behaviour of stem cells, which regenerate the bowel lining, and of immune cells that control inflammation.

The study showed diets high in indole-3-carbinol protected the mice from cancer, even those whose genes put them at very high risk of the disease.

Without the protective diet, the gut cells divided uncontrollably.

Dr Stockinger added: “Even when the mice started developing tumours and we switched them to the appropriate diet, it halted tumour progression.”

Presentational white space

Signs of bowel cancer include persistent:

  • blood in the stools
  • changes in bowel habits, such as going to the toilet more often
  • tummy pain, bloating or discomfort
Presentational white space

Dr Stockinger said the findings were a “cause for optimism”.

She has reduced the amount of meat she eats and now consumes a lot more vegetables.

She told the BBC: “A lot of dietary advice we’re getting changes periodically – it is very confusing and not clear cut what the causes and consequences are.

“Just telling me it’s good for me without a reason will not make me eat it.

“With this study, we have the molecular mechanisms about how this system works.”

Prof Tim Key, from Cancer Research UK, said: “This study in mice suggests that it’s not just the fibre contained in vegetables like broccoli and cabbage that help reduce the risk of bowel cancer, but also molecules found in these vegetables too.

“Further studies will help find out whether the molecules in these vegetables have the same effect in people, but in the meantime there are already plenty of good reasons to eat more vegetables.”

Follow James on Twitter.

More on this story

California School Teacher Out With Cancer Has To Pay The Salary Of Her Substitute

(THIS ARTICLE IS COURTESY OF NBC NEWS)

 

San Francisco parents rally around teacher with cancer who has to pay for her own substitute

Parents at Glen Park Elementary School are pitching in to help the teacher fighting breast cancer cover the costs for her substitute.

 

 

Shanghai China: Focus on cancer prevention

(THIS ARTICLE IS COURTESY OF SHANGHAI CHINA’S ‘SHIELD’ NEWS)

 

Focus on cancer prevention

Cancer morbidity in Shanghai has risen 141 percent in the past four decades, according to the latest data released by local health authorities.

But the rate of deaths among cancer patients dropped by 42 percent in this period due to better screening, registration and monitoring.

This week is the city’s Cancer Prevention and Treatment Week with various events promoting cancer prevention.

An opening ceremony was held on Sunday in Changning District which included a walking race.

Data shows that almost 30 percent of local adults do not engage in physical activities and more than 30 percent are overweight. Nearly 10 percent suffer obesity.

Research shows that 40 percent of the causes of cancer in China are bad habits such as lack of exercise, poor diet, smoking and drinking.

Residents who want to know more about cancer and related activities can find information on the WeChat accounts of the local heath commission and center for disease control and prevention.

By 2015, cancer was the second major cause of death in Shanghai.

More than 70,000 people in Shanghai were diagnosed with cancer and nearly 40,000 died as a result in 2015.

Giving cancer patients hope is as valuable as giving them medicine

(THIS ARTICLE IS COURTESY OF THE TIMES OF ISRAEL)

 

Giving cancer patients hope is as valuable as giving them medicine

Israeli cancer patients rely on ICSN’s volunteers and services to help them cope, fight, and recover

Families grappling with the double pressures of watching their children suffer through cancer while simultaneously having earn a living benefit most from ICSN's services, such as transport and financial assistance.

Families grappling with the double pressures of watching their children suffer through cancer while simultaneously having earn a living benefit most from ICSN’s services, such as transport and financial assistance.

To recover from cancer, having the best doctors, treatment, or medication is not enough. Without hope and personal connection, the prognosis for cancer patients is decidedly poorer. This is exactly why Israel Cancer Support Network (ICSN) offers cancer patients and their families the warmth they need to survive emotionally and the firm support they need to meet the challenges of suffering through painful cancer treatments. 

The emotional, physical, and fiscal strain of treating cancer, from arranging doctors’ appointments to meeting personal expenses and trying to maintain a “normal” family life, are hurdles that many have a tremendously difficult time overcoming.

In less than a decade, ICSN has helped over 11,000 families dealing with cancer, giving 50,000 car rides to cancer patients in need of transportation to the hospital and back. That comes out to 150 trips each day. ICSN uses a network of volunteers to create a community of support throughout Israel. Over 2,000 multilingual volunteers from the Jerusalem metro area and further away take time out of their busy lives to transport cancer-stricken children and adults to and from the hospital, around the clock year-round.

But these services represent only a fraction of what ICSN does.

ICSN sets up fully stocked, 24/7 coffee stations in cancer wards so that patients and families can savor a hot drink at any hour of the day. In its 15-year history, the organization has served over a million cups of coffee to cancer patients. ICSN also assists patients with the herculean task of gaining access to top doctors with long waiting lists for appointments.

The bottom line is that ICSN’s services are integral to the recovery of those who use them.

Many families suffer extreme difficulties as a result of cancer treatment and the financial damage caused by months of treatments can be crippling. Patients often lose their jobs due to the inability to work while parents miss countless hours of work accompanying their children to treatments. ICSN eases the burden by offering cash stipends and gift certificates to cover the cost of household help, including shoes, clothing, basic food items and life-saving drugs.

But beyond the financial, physical, and logistical help they provide, ICSN most importantly furnishes cancer patients with hope.

“A smiling volunteer driver picking you up in the middle of the night with his car to take you to the hospital is just as valuable as the cancer treatment itself,” said Shlomi, a recipient of ICSN’s services.

Personal outreach has a distinct therapeutic effect, according to Professor Dina Ben-Yehuda, director of Hematology at Hadassah Ein-Kerem and professor of Hematology at Hebrew University’s Faculty of Medicine. “When you battle a disease like cancer, the supporters are just as important as the fighters.”

During the High Holidays, ICSN goes the extra mile to give cancer patients in need the serene conditions in which to celebrate and usher in the new year.

ICSN functions entirely through donations with no external support.

Learn more about how you can help cure cancer.

Groundbreaking Treatment Cures Woman’s Advanced Breast Cancer in World First

(THIS ARTICLE IS COURTESY OF THE GUARDIAN)

 

Groundbreaking Treatment Cures Woman’s Advanced Breast Cancer in World First

A Florida woman is still alive thanks to a unique style of immunotherapy in treating her aggressive breast cancer.

Doctors and cancer patients around the world are taking note of an incredible piece of news. A new therapy has reportedly cured a woman diagnosed with advanced breast cancer which had spread throughout her body.

This marks the first time that a woman with advanced, late-stage breast cancer has successfully been treated with immunotherapy. The team of doctors used patient Judy Perkins’s own immune cells to combat the disease.

Perkins was just 49 years old when the engineer discovered she’d been picked for a new therapy. She’d already undergone chemo treatments which continued to fail her. At best, Perkins had three years left to live.

Doctors from the US National Cancer Institute located in Maryland suggested the immunotherapy. They called her response to the treatment “remarkable.”

“My condition deteriorated a lot towards the end, and I had a tumour pressing on a nerve, which meant I spent my time trying not to move at all to avoid pain shooting down my arm. I had given up fighting,” Perkins said in an interview with The Guardian. “After the treatment dissolved most of my tumours, I was able to go for a 40-mile hike.”

Laszlo Radvanyi serves as a scientific director at the Ontario Institute for Cancer Research. Like many keeping up with this news, Radvanyi was not involved in treating Perkins. However, he’s certainly taking notice — calling the treatment “an unprecedented response in such advanced breast cancer.”

“We are now at the cusp of a major revolution in finally realising the elusive goal of being able to target the plethora of mutations in cancer through immunotherapy.”

“We are now at the cusp of a major revolution in finally realising the elusive goal of being able to target the plethora of mutations in cancer through immunotherapy,” Radvanyi said.

Doctors now hope for a major revolution in treatment opportunities available for patients. Some research teams are already developing massive clinical trials to determine just how effective immunotherapy could be for certain patients.

Simon Vincent, director of research at Breast Cancer Now, told interviewers: “This is a remarkable and extremely promising result, but we need to see this effect repeated in other patients before giving hope of a new immunotherapy for incurable metastatic breast cancer.

“Metastatic breast cancer remains incurable, and if we are to finally stop women dying we urgently need to find new ways to target and stop the spread of the disease. We are thrilled by this early finding, but we must remember that this type of immunotherapy remains an experimental approach that has a long way to go before it might be routinely available to patients.”

The process of immunotherapy takes biopsies of the primary tumor and its metastases to determine any mutations specific to a patient’s cancer. Those immune cells that made it through tumor tissue then get cultivated into billions of immune cells in a lab. The tumor tissue itself goes through a bit of gene sequencing so researchers know the main mutations of the tissue. The immune cells being grown then get analyzed to see which ones can target cancer specifically. Those immune cells are the ones that get put back into a patient in order to kill the cancer cells.

SCIENCE

18-Year-Old Boy Designs a Bra That Can Detect Breast Cancer

Perkins had over 80 billion immune cells put into her body. After 42 weeks of treatment, Perkins was declared free of cancer.

She’s been free of cancer ever since.

“It feels miraculous, and I am beyond amazed that I have now been free of cancer for two years,” Perkins said.

“I had resigned my job and was planning on dying. I had a bucket-list of things I needed to do before the end, like going to the Grand Canyon,” she added. “Now, I have gone back to normal everyday life.”

Via: The Guardian

New nano treatment gives cancer patients fresh hope

(THIS ARTICLE IS COURTESY OF SHANGHAI CHINA’S NEWS AGENCY ‘SHINE’)

 

New nano treatment gives cancer patients fresh hope

The world’s first surgery using NanoGun technology — jointly developed by Chinese and French scientists — was performed on a lung cancer patient in Shanghai yesterday.

The new minimally invasive treatment, which can be used on patients deemed no longer healthy enough for chemotherapy, injects the radioactive element rhenium-188 covered with nano-particles, including nitroimidazole — an organic matter.

While engulfing the nitroimidazole, the cancer cells also take in the rhenium, which eventually kills the tumor.

The patient, 71, was in the terminal stage of lung cancer and was too ill for further chemotherapy.

“It usually takes three days for the rhenium to kill the cancer cells,” said Gao Yong, the doctor in charge of the operation at Shanghai East Hospital. “There won’t be any side effects (from the rhenium) as the element will lose its radioactivity after three days.”

NanoGun is a Shanghai-based technology developed from scratch. It won China’s top innovation award in 2016.

Yang Guanghua, one of the scientists who helped develop the technology, said that although rhenium had long been ideal to treat cancer, there had been no ideal medium for delivery. It often diffused throughout the body and was hard to be absorbed by the irregular shaped cancer cells.

It took Yang and his colleges almost 10 years to find the right coating material, nitroimidazole, which matches perfectly with rhenium to make sure it directly reaches the nidus, or “nest”, of the cancer.

“Diffusion of the element (rhenium) hindered the effectiveness of the treatment in the past,” said Dr. Sadeg Nouredine, one of the French scientists working with Yang.

The surgery, approved by the hospital’s ethics committee as part of the treatment’s clinical trial, was free.

“We are working on the next stage of the technology in the lab,” said Yang. “So that it can hit multiple niduses simultaneously.”

If the trial succeeds the treatment will be available by 2020, by which time Shanghai will have built a pharmaceutical factory and hospital in Songjiang District to provide rhenium.

(Humor Poem) Queen Piggy

QUEEN PIGGY

 

Queen Piggy we inherited her when cancer

Took her mommy from this earthly world

She was a mere six months old

When she came prancing and dancing

Into our family’s little fold

 

 

She was so cute you just had to hold and love her

For wherever she was, she always stole the show

Everyone who ever cast their eyes upon her

Would soon lose their heart to this hairy little girl

For 18 wonderful years she ruled our little home

 

 

To her, every hand she met was a new friend

For everyone always wanted to pet and hold her

So cute partly because of her snarly little grin

You see, Queen Piggy was a Pekingese puppy

With smashed snout, hairy toes and toothy smile

 

 

Everyone that she met was now her newest best friend

We loved this little girl as to our home, light she did bring

But now it’s the Angels turn to smile with Queen Piggy

Flying around Heaven tucked up underneath their wings

Here on earth we will always miss her and her sweet love

 

 

All the smiles she brought we will always miss her

But who am I or we to complain of missing her love

For last night in my dreams the scene I did see her

I saw Piggy fast asleep being petted by our Savior

There in Heaven upon the Good Lord’s knee

Thousands of strangers gave a sick child an early Christmas. Days before Thanksgiving, he died.

(THIS ARTICLE IS COURTESY OF THE WASHINGTON POST)

 

Thousands of strangers gave a sick child an early Christmas. Days before Thanksgiving, he died.

 November 20 at 2:28 PM

Jacob Thompson, 9, died Sunday after fighting a rare cancer for four years. (Family photo)

Jacob Thompson spent nearly half of his short life battling cancer.

The 9-year-old boy, who loved penguins, died Sunday, four years after he was diagnosed with Stage 4 neuroblastoma, a rare cancer that affects mostly young children.

As his family had expected, Thompson didn’t live long enough for Christmas, a holiday he loves. But shortly before his death, countless friends, family members and complete strangers inspired by the terminally ill boy’s story brought an early Christmas to him. They decorated his hospital room with a tree, requested a special visit from Santa Claus, and sent him gifts and dozens of homemade holiday cards.

Jacob and his family celebrated Christmas on Nov. 12. He died a week later.

“Each and every person who sent Jacob a Christmas card, a gift, a Facebook message or video, or a prayer made a difference in the final days of his life,” his family, from Saco, Maine, wrote on a Facebook page they used to chronicle his journey. “You brought Jacob joy, and you brought us all optimism for the future. Thank you for taking the time, and taking an interest in our sweet boy’s journey. Sadly, there are many others like him that we hope you will continue to help.”

Jacob was admitted to the hospital “for the last time” Oct. 11, his mother, Michelle Thompson Simard, wrote on a GoFundMe page. The cancer had spread to his skull and to several bones in his inner ear. His hip was so covered with tumors that it looked like lace, Thompson Simard wrote. Chemotherapy and radiation had offered little signs of hope.

The boy’s family was “told that we should be spending as much time as possible with him and we should start making arrangements for his passing,” Thompson Simard wrote, adding later, “No one thinks about having to do this type of planning for their child and because of that we did not nor do not have life insurance on him.”

The GoFundMe campaign has raised nearly $160,000 as of Monday to pay for Jacob’s funeral.

Thompson Simard documented the response from people who sent Christmas cards and toys to make the early holiday memorable for Jacob. On Nov. 1, she posted a picture of Jacob with the first card he received. It featured a penguin, which his family, from Saco, Maine, says is his favorite animal.

For the next several days, Jacob was showered with presents. Pictures his mother shared on social media showed boxes of toys, games, books, cards and, of course, more penguins — including penguin socks.

He even received a video greeting from actor Rob Lowe and the cast of “Code Black.”

Merry Christmas, Jacob! http://dlvr.it/Pyx3zQ  Please send cards:
Jacob Thompson
Maine Medical Center
22 Bramhall St
Portland, ME 04102

Barbara Bush Children’s Hospital in Portland, Maine, where Jacob was being treated, saidthe response was “wonderfully overwhelming” but asked people to not personally deliver cards to the hospital because of safety concerns.

On Thursday, three days before Jacob died, his family shared a picture of him in his hospital bed wearing a blue Superman T-shirt. His dog, Piper, was lying near his feet.

Jacob had just gone through a round of radiation to help him with some pain in his leg, his family wrote.

“Jacob spends most of his time resting, but has had a few good hours to play and open all your cards and gifts,” his family wrote.

In the post announcing Jacob’s death, his family said they hope his story would help raise awareness about neuroblastoma, a rare type of cancerous tumor that affects mostly infants and young children, according to the American Cancer Society. There are about 700 new cases every year in the United States. The majority are diagnosed by age 5.

“We hope that donations will be made, and a cure will be discovered as a result,” Jacob’s family wrote.

Breast Cancer Deaths Drop Nearly 40% In the U.S.

(THIS ARTICLE IS COURTESY OF TIME.COM)

 

Breast Cancer Deaths Drop Nearly 40% In the U.S.

12:04 PM ET
TIME Health
For more, visit TIME Health.

Efforts to improve screening and access to treatment for breast cancer are making a difference nationally, according to the latest figures from the American Cancer Society.

From 1989 to 2015, deaths from the disease dropped by 39%, which translates to 322,600 lives saved from breast cancer. The latest numbers continue a steady downward trend for breast cancer deaths over the past few decades.

In some states, the death rates from breast cancer among white women and black women are equalizing, suggesting that access to screening and treatments are more evenly distributed in those parts of the country.

newsletter
TIME HealthGet the latest health and science news, plus: burning questions and expert tips. View Sample

SIGN UP NOW

But the data still show that black women have the highest death rates from breast cancer nationally. Among black women, the death rate was 42% higher than among white women from 2011 to 2015. Other studies have documented that black women tend to be diagnosed with more advanced-stage cancers, which are harder to treat and have higher mortality rates. Aggressive triple negative cancers that are deadlier are also more common among this group of women.

MOREI Treated Breast Cancer for Years as a Doctor. Then I Was Diagnosed

The overall drop in mortality is a positive sign suggesting that wider mammogram screening and improved treatments for the disease are helping women survive breast cancer. Yet in the U.S., breast cancer remains the most commonly diagnosed cancer among women and the second deadliest. During her lifetime, a woman has a one in eight chance of developing the disease. Ensuring that more states start to equalize access to screening and treatments is critical to sustaining the decline in deaths, say the authors.

Wellness & Beauty Marketing

Isagenix and Avon blog - USA

Blog Pitacos e Achados

Dicas e Pitacos para o dia a dia

Hopeless fountain

Living moments through words.

OSTENDNOMADOGRAPHY

About My Wanderings Through Urban And Nature Landscapes

karmenclair.wordpress.com/

Lifestyle blog dedicated to travel, food, nature and other ramblings

Everything Is Hack!

Find here all information on mental health, travel tips, and generally lifestyle questions answered! Whatever you need to know, this is the place for you.

Capt Jills Journeys

She sails the seven seas in search of FREEDOM

%d bloggers like this: